Class II major histocompatibility complex tetramer staining: progress, problems, and prospects
- 30 January 2008
- journal article
- review article
- Published by Wiley in Immunology
- Vol. 123 (3) , 305-313
- https://doi.org/10.1111/j.1365-2567.2007.02801.x
Abstract
The use of major histocompatibility complex (MHC) tetramers in the detection and analysis of antigen-specific T cells has become more widespread since its introduction 11 years ago. Early challenges in the application of tetramer staining to CD4+ T cells centred around difficulties in the expression of various class II MHC allelic variants and the detection of low-frequency T cells in mixed populations. As many of the technical obstacles to class II MHC tetramer staining have been overcome, the focus has returned to uncertainties concerning how oligomer valency and T-cell receptor/MHC affinity affect tetramer binding. Such issues have become more important with an increase in the number of studies relying on direct ex vivo analysis of antigen-specific CD4+ T cells. In this review we discuss which problems in class II MHC tetramer staining have been solved to date, and which matters remain to be considered.Keywords
This publication has 98 references indexed in Scilit:
- Antigen-Specific CD4+T Cells Recognize Epitopes of Protective Antigen following Vaccination with an Anthrax VaccineInfection and Immunity, 2007
- CD8 exerts differential effects on the deployment of cytotoxic T lymphocyte effector functionsEuropean Journal of Immunology, 2007
- Myelin-specific regulatory T cells accumulate in the CNS but fail to control autoimmune inflammationNature Medicine, 2007
- Tetramer visualization of gut-homing gluten-specific T cells in the peripheral blood of celiac disease patientsProceedings of the National Academy of Sciences, 2007
- Quantum dot/peptide-MHC biosensors reveal strong CD8-dependent cooperation between self and viral antigens that augment the T cell responseProceedings of the National Academy of Sciences, 2006
- In vivo biotinylation of the major histocompatibility complex (MHC) class II/peptide complex by coexpression of BirA enzyme for the generation of MHC class II/tetramersHuman Immunology, 2004
- Directed Evolution of Soluble Single-chain Human Class II MHC MoleculesJournal of Molecular Biology, 2004
- MHC class II tetramers containing influenza hemagglutinin and EBV EBNA1 epitopes detect reliably specific CD4+ T cells in healthy volunteersHuman Immunology, 2004
- Structural basis for the binding of an immunodominant peptide from myelin basic protein in different registers by two HLA-DR2 proteinsJournal of Molecular Biology, 2000
- Predominant naturally processed peptides bound to HLA-DR1 are derived from MHC-related molecules and are heterogeneous in sizeNature, 1992